Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ariyasu

Showing results (171-180 of 313) with videos related to

Pageof 32
Sort By:
The Journal of Investigative Dermatology|January 27, 2019
Analysis of the Tumor Reactivity of Tumor-Infiltrating Lymphocytes in a Metastatic Melanoma Lesion that Lost Major Histocompatibility Complex Class I Expression after Anti-PD-1 TherapyTakashi Inozume, Tomonori Yaguchi, Ryo Ariyasu, et al.
Endocrine Journal|October 5, 2020
Distinct clinical features and prognosis between persistent and temporary thyroid dysfunctions by immune-checkpoint inhibitorsHidefumi Inaba, Hiroyuki Ariyasu, Hiroshi Iwakura, et al.
Cancer Chemotherapy and Pharmacology|September 19, 2020
Efficacy of EGFR tyrosine kinase inhibitors in patients having EGFR-activating mutations with or without BIM polymorphismsRyo Ariyasu, Noriko Yanagitani, Kenichi Tadokoro, et al.
Scientific Reports|July 7, 2025
Identifying risk factors of biliary tract cancers using a large Japanese regional insurance claims databaseTatsunori Satoh, Yoshihiro Tanaka, Eiji Nakatani, et al.
Angewandte Chemie (International Ed. in English)|December 15, 2022
A Compound I Mimic Reveals the Transient Active Species of a Cytochrome P450 Enzyme: Insight into the Stereoselectivity of P450-Catalysed OxidationsKazuto Suzuki, Joshua Kyle Stanfield, Keita Omura, et al.
Endocrine Journal|May 21, 2011
High iFGF23 level despite hypophosphatemia is one of the clinical indicators to make diagnosis of XLHJunko Miyamoto Igaki, Makoto Yamada, Yuji Yamazaki, et al.
Investigational New Drugs|September 24, 2022
EGFR-TKI re-administration after osimertinib failure in T790M mutation loss cases with re-biopsyShinsuke Ogusu, Ryo Ariyasu, Takahiro Akita, et al.
Internal Medicine (Tokyo, Japan)|March 2, 2018
Fulminant Type 1 Diabetes Mellitus Accompanied by Positive Conversion of Anti-insulin Antibody after the Administration of Anti-CTLA-4 Antibody Following the Discontinuation of Anti-PD-1 AntibodyMichiru Shiba, Hidefumi Inaba, Hiroyuki Ariyasu, et al.
American Journal of Physiology. Endocrinology and Metabolism|November 25, 2011
Transgenic overexpression of intraislet ghrelin does not affect insulin secretion or glucose metabolism in vivoMika Bando, Hiroshi Iwakura, Hiroyuki Ariyasu, et al.
International Journal of Cancer|March 16, 1995
Alternative splicing of the neurofibromatosis 1 gene correlates with growth patterns and neuroendocrine properties of human small-cell lung-carcinoma cellsT Koh, J Yokota, K Ookawa, et al.
Pageof 32

Showing results (171-180 of 313) with videos related to

Sort By:
Pageof 32
The Journal of Investigative Dermatology|January 27, 2019
Analysis of the Tumor Reactivity of Tumor-Infiltrating Lymphocytes in a Metastatic Melanoma Lesion that Lost Major Histocompatibility Complex Class I Expression after Anti-PD-1 TherapyTakashi Inozume, Tomonori Yaguchi, Ryo Ariyasu, et al.
Endocrine Journal|October 5, 2020
Distinct clinical features and prognosis between persistent and temporary thyroid dysfunctions by immune-checkpoint inhibitorsHidefumi Inaba, Hiroyuki Ariyasu, Hiroshi Iwakura, et al.
Cancer Chemotherapy and Pharmacology|September 19, 2020
Efficacy of EGFR tyrosine kinase inhibitors in patients having EGFR-activating mutations with or without BIM polymorphismsRyo Ariyasu, Noriko Yanagitani, Kenichi Tadokoro, et al.
Scientific Reports|July 7, 2025
Identifying risk factors of biliary tract cancers using a large Japanese regional insurance claims databaseTatsunori Satoh, Yoshihiro Tanaka, Eiji Nakatani, et al.
Angewandte Chemie (International Ed. in English)|December 15, 2022
A Compound I Mimic Reveals the Transient Active Species of a Cytochrome P450 Enzyme: Insight into the Stereoselectivity of P450-Catalysed OxidationsKazuto Suzuki, Joshua Kyle Stanfield, Keita Omura, et al.
Endocrine Journal|May 21, 2011
High iFGF23 level despite hypophosphatemia is one of the clinical indicators to make diagnosis of XLHJunko Miyamoto Igaki, Makoto Yamada, Yuji Yamazaki, et al.
Investigational New Drugs|September 24, 2022
EGFR-TKI re-administration after osimertinib failure in T790M mutation loss cases with re-biopsyShinsuke Ogusu, Ryo Ariyasu, Takahiro Akita, et al.
Internal Medicine (Tokyo, Japan)|March 2, 2018
Fulminant Type 1 Diabetes Mellitus Accompanied by Positive Conversion of Anti-insulin Antibody after the Administration of Anti-CTLA-4 Antibody Following the Discontinuation of Anti-PD-1 AntibodyMichiru Shiba, Hidefumi Inaba, Hiroyuki Ariyasu, et al.
American Journal of Physiology. Endocrinology and Metabolism|November 25, 2011
Transgenic overexpression of intraislet ghrelin does not affect insulin secretion or glucose metabolism in vivoMika Bando, Hiroshi Iwakura, Hiroyuki Ariyasu, et al.
International Journal of Cancer|March 16, 1995
Alternative splicing of the neurofibromatosis 1 gene correlates with growth patterns and neuroendocrine properties of human small-cell lung-carcinoma cellsT Koh, J Yokota, K Ookawa, et al.
Pageof 32